← All stocks

GMED vs PODD

Globus Medical Inc. Class A Common Stock vs Insulet Corporation Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
GMED
PODD
Composite score
Out of 100
56
62
Growth
28
88
Value
72
55
Quality
78
89
Momentum
46
17
Valuation
GMED
PODD
Price
74.08
140.60
Market cap
9.95B
9.75B
Trailing P/E
18.95
26.38
Forward P/E
13.91
18.21
EV / EBITDA
9.92
15.58
Dividend yield
0.0%
0.0%
Profitability
GMED
PODD
ROE
11.8%
26.0%
Net margin
17.0%
12.3%
Debt / equity
0.00
0.63
Free cash flow
588.77M
377.70M
Growth
GMED
PODD
Revenue growth (YoY)
5.9%
23.5%
Earnings growth (YoY)
-26.2%
3.3%
Analyst target
103.23
171.91
See full analysis